GB Group. PCA acquisition an excellent fit. PCA adds SME reach to address intelligence services. Earnings enhancing despite growth investment

Similar documents
Paysafe Group. Growth normalises. Growth moderates in H117. Pro forma financials show potential impact of deals

K3 Business Technology

TXT e-solutions. Strong cash flow supports dividend boost. PACE acquisition boosts FY16 performance. Minor changes to earnings forecasts

Eddie Stobart Logistics

JackpotJoy plc. A transformational year. Revenue and EBITDA slightly ahead of estimates. Strong operating cash flow dividends from 2019

TXT e-solutions. Steady growth in Q3. Growth for both businesses in Q3. Outlook and changes to forecasts

Centrale del Latte d'italia

Mondo TV. YooHoo! Netflix deal drives significant upgrades. Global deal with Netflix, new Chinese productions. Significant increase to five-year plan

Centrale del Latte d'italia

TerraNet Holding. Irons in the fire. Five new strategic development orders won in Q317. Cash flow burn reflecting multi-project activity

Monitise. FY14 growth on track. Focus on expanding the network. Guidance maintained for FY14. Valuation: Reflects growth potential.

Piteco. Bold entry into the US marketplace. Acquisition of US payments software provider. Forecasts: FY18 revenues rise by 34%, EPS by 12%

Carr s Group. Diversification continues to give resilience. PBT up for H117 as UK farmers gain in confidence

Evolva. EverSweet. Delivering on the new strategy. FY17 results. Valuation: Fair value of CHF0.60 per share. FY17 results.

K3 Business Technology

OTC Markets Group. Record quarterly revenues. Q115 Corporate services revenue rises 54% Operating expenses rise 18% in Q115.

Ubisense. Geographic expansion. Ubisense acquires Asian partner. Expanding the opportunity in Asia. Changes to forecasts

GFT Group. IT services pure-play focused on banks. Disposal of emagine. Acquisition of Adesis Netlife SL. Forecasts: Adjusted for effects of the deals

KEFI Minerals. Counting down to production. Outstanding matters. Valuation: 6.55p/sh in FY18 rising to 7.21p/sh in FY19.

International Stem Cell

XP Power. Strong demand drives record performance in H1. H118 sees continuation of strong growth

ReNeuron Group. US exclusivity deal - more than non-dilutive cash. FY18 results: Strong cash balance. Funded for a busy programme

Shanks Group. Global commodity crisis offsetting progress. Netherlands Commercial progress encouraging

Sealegs Corporation. Sea change. H1 update. Changing business mix. Valuation: New focus improves valuation. H1 results

Circle Property. Lifting estimates again. Revaluation gains and strong rent growth. Upside potential from refurbished assets

Gear4music Holdings. Market share gains and margin boost. Strong pre-christmas trading. FY18 forecast maintained

artnet For art's sake FY15: Art fair partnerships and forays to China Intended reporting change Valuation: Overshadowed Q1 figures

The Quarto Group. Good visibility into H2. Building on strengths. Group in improving shape for CFO transition. Valuation: Discount remains substantial

Quixant. A very promising year ahead. Volume deliveries to new major customers. Current order book over double the prior year

Regional REIT. Asset growth and refinancing completed. Further portfolio growth and diversification. Acquisition benefit offset by underlying revision

Antofagasta. Q3 production and costs better than forecast. Q313 production ahead of forecast. FY13 EPS forecast upgraded

Carclo. Contract delays to affect H218 performance. Delayed placement of contracts by customers. Non-medical demand lower than forecast.

Carclo. All going to plan. TP benefiting from expansion to support customers. FLTC acquisition supports further Wipac growth

Progress in a backward market

WANdisco. Cloud OEM agreement with Virtustream/Dell. Second OEM, first for cloud. Cloud credentials strengthened

Medserv. Pieces fitting into place H118. On track to deliver growth. Valuation: Backlog underpins uplift. H118 results. Industrial support services

Centrale del Latte d'italia

Avalon Rare Metals. Refining Nechalacho s future. Nechalacho changing shape significantly. Agreement with Northwest Territory Métis Nation

Expert System. Building the foundations for growth. Contract wins delayed by integration efforts. Company confident that outlook remains positive

Regional REIT. Retail eligible bond 4.5% Regional markets have remained robust. Retail eligible bond offering. Launch of bond issue.

GLG Life Tech. Luo Han Guo drives revenue growth. Tate & Lyle LHG contract boosts top line. H3 and H4 leaf should improve stevia margins

LPE sector performance

Tourism Holdings. ROCE exceeds 14% long-term target. Key drivers remain positive. Deeper customer relationships to drive yield

China Water Affairs Group

Helma Eigenheimbau. Scale research report - Update. Market bottlenecks limiting momentum. H117 results showing moderate growth

Mondo TV. Guidance raised for full year. H117 highlights: Strong licensing sales. Outlook: Net profit guidance raised

Cooks Global Foods. Focused on capital requirements results restated. CGF budgets for 650 stores, targets 800 by 2021

Pura Vida Energy. Reaction to drilling. Sharp sell-off on no news. Results expected no earlier than late July. Increased stock volatility not unusual

Carr's Group. Profits dip as expected with FY18 recovery underway. FY17 impacted by external factors. FY18 recovery underway

Polypipe Group. Strong Residential performance. Sector themes maintained, some portfolio tweaks. French disposal modestly dilutive to earnings

Vectron Systems. Scale research report - Update. Evolving the business. Boost from regulatory changes recedes. Increased focus on cloud services

NAHL Group. Maiden interims show strong profit growth. Significant rise in margins in H114. FY14e and FY15e PBT and EPS estimates raised

Ceres Power Holdings. Progressing towards commercialisation. Progressing the technology. Securing routes to market

SNP Schneider-Neureither & Partner

paragon Accelerating progress Q2 displays accelerating performance Guidance changes reflect growth initiatives Valuation: Rating not reflecting growth

Global Bioenergies. String of successes and new financing. Forecasts updated to reflect results & new financing

Aberdeen Asset Management

Evolva. A cloudier picture. Production update agreement not yet reached. FY16 revenue lower than previously expected

TransContainer. Russian rail volumes continue to grow. Story intact: Runaway market growth. EBITDA growth set to continue

Boku. Strong H1 supports future growth. Strong volume growth continues in H118. Investing for sustained growth. Valuation: Premium for growth

ADVA Optical Networking FY12 results

High-impact exploration offshore Philippines

SITO Mobile. A strong end to a transformational year. Transformational year ends on a high note. Pipeline looks promising

Cooks Global Foods. Funded for growth. Growth plans. Interim results. Valuation: Upside in valuation. Interim results.

Athersys. Progress on all fronts. Timeline for FDA approval accelerated. mrs shift analysis is primary endpoint. Moving forward in Japan

Caledonia Mining. Production in line, EPS down on macro factors. Record quarterly production. New (lower) gold price forecasts

Record. Maintaining client commitment. FY18 result. Outlook: Seeing well-diversified interest. Valuation. FY18 results. Financial services

InMed Pharmaceuticals

Rockhopper Exploration

Sigma Capital Group. New funding structure to finance project growth. JV to deliver initial 200m portfolio of 2,000 homes.

Thin Film Electronics

The Quarto Group. 40 years young. Children s list delivers on promise. Investing in new titles, building IP for future sales

Expert System. Turning the AI hype into reality. Pace of new business accelerated in H2. Increasing interest in commercial application of AI

Oceania Natural. NXT Company Spotlight. Preliminary results and delisting proposal. Preliminary results at March 2018: Increased loss

Entertainment One. PJ Masks catching Peppa. Strong growth in profitability. PJ Masks joins Peppa as a global Family brand

Kongsberg Automotive investment headwind, but technology wins results affected by investment, but progress

Bionomics. PTSD programme on track for results in Q3. PTSD treatment complete, results coming. Agitation study ongoing

AFH Financial Group. Delivering on acquisitions and organic growth. FY15 results: Beating expectations on organic growth

Game Digital. Not a game changer. Early days in the strategic transition. Trading update: Short-term timing delays

S&U. Positioning for sustainable growth. H119 results. Adapting to market background. Valuation: Maintained on slightly lower estimates.

K3 Business Technology Update on preliminary results

Park Group. Continued growth in earnings and cash. Small forecast increase, awaiting IFRS 15. New management team takes up the baton

Ceres Power Holdings. Strengthening customer engagement. Customer engagement intensifying. Engagement underpinned by technology advances

Intec Pharma. Phase III more than half the way there. Gastroscopy substudy complete. New pharmacokinetic study on deck. New plan for AP cannabinoids

RNTS Media. Scaling up with acquisitions. Mediation platform very well received. Product launches - growth should pick up in H2

Tungsten Corporation. Focusing on growth and efficiency. AGM update. Outlook. Valuation. Company update. Financial services

aap Implantate AG Biomaterials for sale as LOQTEQ growth takes off Robust growth driven by LOQTEQ in FY14 Sale of Biomaterials under review

Mercia Technologies. Good progress across the portfolio. 17.7% growth in direct investment portfolio. Commercial traction in key companies

Pan African Resources

TransGlobe Energy. EGPC receivables issue resolved. EGPC makes significant receivables reduction. Focus in Egypt shifts from seismic to drilling

PPHE Hotel Group. More of the same. Continued outperformance. Favourable asset management climate. Valuation: Closing the discount to NAV

Bellus Health. Thallion deal likely as Jaguar backs revised CVRs. CVR revisions mostly modest; Jaguar supports bid

Photocure. Nordic sales bounce back. Eight more blue light cystoscopy units placed in US. Hexvix/Cysview added to bladder cancer guidelines

Vislink. Conditional sale of hardware division. Industry evolution affected VCS performance. Group expected to return to profitability in FY17

PDL BioPharma. An update on several fronts. Valeant has not been reporting or paying on time. Auvi-Q recalled, but there is an interest reserve

Crossject. A reinforced cash position. Zeneo Midazolam targets under-served market. Pipeline expected to progress in 2017

Galaxy Resources. Mt Cattlin - early mover in lithium project pipeline. Innovation in lithium concentrate processing

Pantaflix. Scale research report Update. Name change reflects VOD strategy. Progressing its VOD strategy. Overview of H117 results

Deutsche Beteiligungs

Astex Pharmaceuticals

Transcription:

GB Group PCA acquisition an excellent fit Acquisition Software & comp services The acquisition of PCA Predict is an excellent fit with GB Group s (GBG) address intelligence services, adding SME reach and, combined with Matchcode360 and Loqate, providing GBG with the most complete offer in the industry. GBG has closed a 58m placing to fund the 66m acquisition (EV), which it will supplement with existing cash and debt. Despite the planned increase in investment to expand PCA outside the UK, the deal should be earnings enhancing and we upgrade our FY18 and FY19 EPS forecasts by 8.5% and 10.4%, respectively. 11 May 2017 Price 385p Market cap 585m Net cash as at 31 March 2017 5.2 Shares in issue 152m Free float 97% Code GBG Year end Revenue EBIT* PBT* EPS* (p) 03/16 73.4 13.4 13.2 8.2 2.1 47.0 0.5 03/17e 87.5** 17.0** 16.5 9.7 2.2 39.7 0.6 DPS (p) P/E (x) Yield (%) 03/18e 117.1 23.3 22.6 11.5 2.5 33.5 0.6 03/19e 133.4 27.3 26.7 13.4 2.8 28.7 0.7 Note: *EBIT, PBT and EPS (fully diluted) are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. **Reported in trading update. Primary exchange Secondary exchange Share price performance AIM N/A PCA adds SME reach to address intelligence services PCA Predict provides type-ahead address look-up functionality to SMEs in order to improve customer experience and conversion rates. PCA has over 9,000 SME customers to its self-serve cloud-based platform, providing a highly complementary fit to GBG s existing enterprise focused services in this area (Loqate and Matchcode360). The combined business will have the broadest offering on the market and management believes that there are other synergy opportunities from the cross sell of GBG s other services. GBG is paying net 66m for the business; a total consideration of 78m reflects 10m cash acquired with the company and 2m fees. To finance the acquisition, GBG has placed 17.1m new shares at 340p, raising 58m, and will supplement this with cash on hand and debt drawn from existing facilities. Earnings enhancing despite growth investment Management estimates the global addressable market for address intelligence services at $1bn, of which the UK is c 15%. PCA has grown its revenues at doubledigit rates over the last two years, but its customer base remains largely UK oriented. It plans to invest to enable the enlarged division to target the US and Australian markets, where it is currently under-represented. Despite this step up in investment, we expect the deal to be earnings enhancing from the first year and upgrade our FY18 and FY19 EPS by 8.5% and 10.4%, respectively. Valuation: Fairly priced GBG is paying a multiple of 14.0x EV/EBITDA and 20.3x P/E for PCA (12 months to February 2017), a full but fair price given the strategic value it brings to GBG, and still considerably below GBG s own rating. Chris Clarke, incoming CEO at GBG, is steeped in experience in this segment from his time at Experian, and we are optimistic that cross-selling opportunities and plans to invest outside the UK should ensure strong growth into the medium term. % 1m 3m 12m Abs 32.3 28.7 27.9 Rel (local) 30.9 25.4 6.7 52-week high/low 376.00p 215.00p Business description GB Group (GBG) has complementary identity data intelligence offerings of verification, capture, maintenance and analysis, enabling companies to identify and understand their customers. Next events FY results 6 June 2017 Analysts Bridie Barrett +44 (0)20 3077 5700 Dan Ridsdale +44 (0)20 3077 5729 Katherine Thompson +44 (0)20 3077 5730 tech@edisongroup.com Edison profile page GB Group is a research client of Edison Investment Research Limited

PCA Predict acquisition PCA type ahead look-up functionality PCA (derived from Post Code Anywhere) is a UK-based provider of postal address, mobile and email data cleansing and verification in order to improve the customer data entry experience and ultimately customer conversion rates. It runs a cloud-based self-serve platform for its 9,000, largely SME customer base, however it also sells into some larger accounts (for example Allianz, ASOS, Atos, Countrywide, William Hill). PCA s headquarters are in Worchester, UK, where the majority of its 50 employees are located. It also has small satellite operations in the US and Germany. Deal rationale Scale and reach: GBG s US-based Loqate has a predominantly enterprise customer base, sold via channel partners, and UK-based Matchcode also serves a largely enterprise grade customer. PCA s self-serve, cloud-based platform gives GBG reach into the SME market. Leading position: Management believes that post this acquisition, GBG will have the most complete solution in the address intelligence services market. Its largest competitors in this segment include Experian (Experian Data Quality), Informatica (Address Doctor) and to a lesser extent Google s Auto Address functionality (although this only goes as far as street level). However, these services do not have an SME capability, nor the granularity of reference data that can be offered by GBG post this acquisition. Synergies: GBG will add data access from the wider group to enhance the PCA service offer. The acquisition should also enable GBG to cross sell its other services into PCA s client base. For example, regulated customers such as lawyers or IFAs may be interested in the verification tools. The technology will be integrated with GBG Loqate and GBG Matchcode and the use of a common technology platform should enable scale benefits related to data sourcing. Expansion to the US and Australia: GBG estimates the address intelligence market is worth approximately $1bn. PCA is currently largely UK-focused. Under the GBG umbrella, management plans to introduce a common brand and add new data sources to grow its footprint in the US and Australia. Exhibit 1: PCA Predict complements Matchcode and Loqate Source: GB Group Acquisition terms and impact on forecasts The total consideration for the deal is 78m, reflecting an enterprise value of 66m, 10m cash acquired with PCA and 2m in deal fees. Of this consideration, 10m will be placed in escrow to GB Group 11 May 2017 2

cover any potential warranties, indemnities, potential competition authority reviews and other conditions. To finance the acquisition, GBG has placed 17.1m new shares at 340p (a 3.4% discount to the price on 8 May), raising 58m. The balance will be financed by existing cash reserves and borrowings of 10m under existing bank facilities. PCA reported double-digit revenue growth in FY15 (+18%) and FY17 (+16.5% for the 12 months to February) and management expects double-digit revenue growth to continue in the current year. PCA runs a self-serve cloud-based platform to customers. This means that the gross margin was approximately 10pp lower than GBG s equivalent business (due to commissions paid to channel partners, payment service providers hosting costs and scale benefits). However, as there is no direct salesforce, the operating margin (33% in FY17) is higher than GBG s. In our forecasts we reflect plans to immediately reconfigure the sales effort to enable the crossselling of GBG s services, and the investment in new reference data sources in the US and Australian markets, and consequently we expect EBIT margins to decrease to approximately 27%. We forecast PCA revenues of 14.5m (on a reported basis) in FY17 and 18.1m in FY19, which implies an average revenue growth of 16% over the period FY17 to FY19. Over time, we believe there could be scope to increase the gross margin as PCA benefits from GBG s scale in sourcing data. This would represent upside to our current margin estimates. We update our forecasts to reflect the acquisition and financing and have also taken the opportunity to update for GBG s headline FY17 revenue and EBITA figures, announced in April. Changes are summarised in Exhibit 2 and presented in full in Exhibit 3. Overall, we increase our EBITA estimates by approximately 19% in both FY18 and FY19. The dilution impact from the placing and the additional 10m of debt financing mean that at the EPS level we increase forecasts by 8.5% in FY18 and 10.4% in FY19. Exhibit 2: Summary forecast changes 000s 2017e 2018e 2019e Previous New % change Previous New % change Previous New % change Revenues 89,000 87,500-1.7 105,000 117,093 11.5 118,125 133,352 12.9 EBITA 16,574 17,000 2.6 19,600 23,300 18.9 22,900 27,300 19.2 PBT 15,917 16,500 3.7 19,008 22,550 18.6 22,308 26,700 19.7 EPS - normalised, diluted (p) 9.4 9.7 3.4 10.6 11.5 8.5 12.1 13.4 10.4 Source: Edison Investment Research GB Group 11 May 2017 3

Exhibit 3: Financial summary 000s 2014 2015 2016 2017e 2018e 2019e Year end 31 March IFRS IFRS IFRS IFRS IFRS IFRS PROFIT & LOSS Revenue 41,835 57,283 73,401 87,500 117,093 133,352 Cost of Sales (14,473) (16,448) (17,606) (11,693) (28,822) (32,798) Gross Profit 27,362 40,835 55,795 75,807 88,271 100,555 EBITDA 7,849 11,844 14,772 19,200 26,200 30,605 Operating Profit (before amort. and except.) 7,164 10,790 13,428 17,000 23,300 27,300 Acquired intangible amortisation (1,110) (1,986) (2,501) (2,540) (2,540) (2,540) Exceptionals (1,080) (1,629) (94) (1,200) (2,200) 0 Share of associate (159) (10) 0 0 0 0 Share based payments (747) (971) (1,245) (1,600) (1,750) (1,699) Operating Profit 4,068 6,194 9,588 11,660 16,810 23,061 Net Interest (79) (266) (270) (500) (750) (600) Profit Before Tax (norm) 7,085 10,524 13,158 16,500 22,550 26,700 Profit Before Tax (FRS 3) 3,989 5,928 9,318 11,160 16,060 22,461 Tax (474) (1,127) (178) (3,630) (4,961) (5,874) Profit After Tax (norm) 5,597 8,314 10,395 12,870 17,589 21,093 Profit After Tax (FRS 3) 3,515 4,801 9,140 7,530 11,099 16,587 Average Number of Shares Outstanding (m) 109.6 119.1 122.7 127.8 147.8 152.5 EPS - normalised (p) 5.1 7.0 8.5 10.1 11.9 13.8 EPS - normalised and fully diluted (p) 4.8 6.7 8.2 9.7 11.5 13.4 EPS - (IFRS) (p) 3.2 4.0 7.4 5.9 7.5 10.9 Dividend per share (p) 1.7 1.9 2.1 2.2 2.5 2.8 Gross Margin (%) 65.4 71.3 76.0 86.6 75.4 75.4 EBITDA Margin (%) 18.8 20.7 20.1 21.9 22.4 23.0 Operating Margin (before GW and except.) (%) 17.1 18.8 18.3 19.4 19.9 20.5 BALANCE SHEET Fixed Assets 26,985 51,238 59,364 94,424 165,684 162,489 Intangible Assets 23,329 45,296 54,113 88,573 159,933 157,243 Tangible Assets 1,519 2,829 2,234 2,834 2,734 2,229 Other fixed assets 2,137 3,113 3,017 3,017 3,017 3,017 Current Assets 23,775 33,186 36,189 51,945 67,339 86,202 Debtors 11,929 17,408 23,774 34,555 49,073 56,377 Cash 11,846 15,778 12,415 17,390 18,267 29,825 Other 0 0 0 0 0 0 Current Liabilities (17,861) (30,784) (32,559) (40,640) (52,158) (57,162) Creditors (17,861) (24,305) (30,927) (39,008) (50,526) (55,530) Contingent consideration 0 (5,733) (1,050) (1,050) (1,050) (1,050) Short term borrowings 0 (746) (582) (582) (582) (582) Long Term Liabilities (2,066) (7,506) (6,593) (17,751) (24,851) (20,851) Long term borrowings 0 (3,643) (3,160) (14,318) (21,418) (17,418) Contingent consideration 0 (895) 0 0 0 0 Other long term liabilities (2,066) (2,968) (3,433) (3,433) (3,433) (3,433) Net Assets 30,833 46,134 56,401 87,978 156,015 170,678 CASH FLOW Operating Cash Flow 9,355 11,684 13,397 15,300 21,000 28,305 Net Interest (79) (266) (282) (500) (750) (600) Tax 65 (337) (248) (3,630) (4,961) (5,874) Capex (1,144) (2,011) (1,762) (2,700) (2,700) (2,650) Acquisitions/disposals (1,443) (18,672) (12,263) (37,100) (74,000) 0 Financing 416 10,954 790 25,000 58,000 0 Dividends (1,632) (1,955) (2,277) (2,553) (2,812) (3,622) Net Cash Flow 5,538 (603) (2,645) (6,183) (6,223) 15,559 Opening net debt/(cash) (6,308) (11,846) (11,389) (8,673) (2,490) 3,733 HP finance leases initiated 0 0 0 0 0 0 Other 0 146 (71) 0 0 0 Closing net debt/(cash) (11,846) (11,389) (8,673) (2,490) 3,733 (11,825) Source: GB Group (historics), Edison Investment Research (forecasts) GB Group 11 May 2017 4

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com DISCLAIMER Copyright 2017 Edison Investment Research Limited. All rights reserved. This report has been commissioned by GB Group and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are wholesale clients for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a personalised service and, to the extent that it contains any financial advice, is intended only as a class service provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited ( FTSE ) FTSE 2017. FTSE is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE s express written consent. Frankfurt +49 (0)69 78 8076 960 GB Schumannstrasse Group 34b 11 May 2017 280 High Holborn 245 Park Avenue, 39th Floor Level 12, Office 1205 5 60325 Frankfurt Germany London +44 (0)20 3077 5700 London, WC1V 7EE United Kingdom New York +1 646 653 7026 10167, New York US Sydney +61 (0)2 8249 8342 95 Pitt Street, Sydney NSW 2000, Australia